Flexi-VACOP/B followed by high-dose cytoxan (CY) and high dose therapy plus autologous peripheral blood progenitor cell (PBPC) rescue for aggressive NHL with bone marrow involvement at diagnosis

被引：0
|
作者：
Congiu, AM [1 ]
Coser, P [1 ]
Leoni, P [1 ]
Salvagno, L [1 ]
Santini, G [1 ]
机构：
[1] S Martino Hosp, Dept Haematol, Genova, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1998年 / 102卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：325 / 325
页数：1
相关论文
共 50 条
  • [41] Repetitive high-dose therapy with dose escalated CHOP plus Etoposide followed by autologous stem cell transplantation (Mega-CHOEP) in younger patients with primary diagnosis of aggressive NHL and elevated LDH at diagnosis: Final analysis
    Schmitz, N
    Kloess, M
    Engert, A
    Berdel, WE
    Metzner, B
    Truemper, L
    Loeffler, M
    Pfreundschuh, M
    Glass, B
    BLOOD, 2004, 104 (11) : 176A - 176A
  • [42] High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma
    Long, GD
    Chao, NJ
    Hu, WW
    Negrin, RS
    Wong, RM
    Blume, KG
    CANCER, 1996, 78 (12) : 2502 - 2509
  • [43] Tandem cycle high-dose melphalan and intravenous busulfan/cytoxan with peripheral blood progenitor cell rescue (PBPC) followed by interferon α-2 (IF) with, or without thalidomide (Thal) for multiple myeloma.: High complete response rate and moderate toxicities.
    Somlo, G
    Yamamoto, N
    Sarah, C
    O'Donnell, M
    Snyder, D
    Sahebi, F
    Kogut, N
    Spielberger, R
    Molina, A
    Parker, P
    Popplewell, L
    Fung, H
    Rodriguez, R
    Stein, A
    Krishnan, A
    Chow, W
    Lopez, F
    Forman, S
    BLOOD, 2001, 98 (11) : 685A - 685A
  • [44] HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT IN THE OUTPATIENT SETTING
    MICHELSON, GC
    GRINBLATT, D
    BYRNEMALLOY, R
    ZIMMERMAN, T
    WILLIAMS, SF
    CLINICAL RESEARCH, 1994, 42 (03): : A378 - A378
  • [45] High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma
    Gianni, AM
    Bregni, M
    Siena, S
    Brambilla, C
    DiNicola, M
    Lombardi, F
    Gandola, L
    Tarella, C
    Pileri, A
    Ravagnani, F
    Valagussa, P
    Bonadonna, G
    Stern, AC
    Magni, M
    Caracciolo, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (18): : 1290 - 1297
  • [46] PROLONGED IMPAIRMENT OF HEMATOPOIESIS AFTER HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    DOMENECH, J
    LINASSIER, C
    GIHANA, E
    DAYAN, A
    TRUGLIO, D
    BOUT, M
    PETITDIDIER, C
    DELAIN, M
    PETIT, A
    BREMOND, JL
    DESBOIS, I
    LAMAGNERE, JP
    COLOMBAT, P
    BINET, C
    BLOOD, 1995, 85 (11) : 3320 - 3327
  • [47] Role of parenteral nutrition in cancer patients undergoing high-dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation
    Tartarone, A
    Wunder, J
    Romano, G
    Ardito, R
    Iodice, G
    Mazzuoli, S
    Barone, M
    Matera, R
    Di Renzo, N
    TUMORI JOURNAL, 2005, 91 (03): : 237 - 240
  • [48] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW RESCUE IN SMALL CELL LUNG-CANCER
    WILSON, C
    PICKERING, D
    STEWART, S
    VALLIS, K
    KALOFONOS, H
    CROSS, A
    SNOOK, D
    GOLDMAN, J
    MCKENZIE, CG
    EPENETOS, AA
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 900 - 900
  • [49] High-dose melphalan (HDM) and G-CSF stimulated whole blood rescue followed by busulphan/cyclophosphamide (BU/CY) and autologous peripheral blood (PB) or bone marrow stem cell (BM) transplantation in multiple myeloma (MM).
    Admiraal, GC
    de Kreuk, AM
    Jonkhoff, AR
    Gloudemans, IJM
    Schuurhuis, GJ
    Ossenkoppele, GJ
    Huijgens, PC
    BONE MARROW TRANSPLANTATION, 1998, 21 : S201 - S201
  • [50] High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors
    Papadakis, V
    Dunkel, IJ
    Cramer, LD
    Kramer, E
    Papadopoulos, E
    Goldman, S
    Packer, RJ
    Willoughby, M
    Baker, D
    Garvin, J
    Strandjord, S
    Coccia, P
    Kaplan, AM
    Klemperer, M
    Finlay, JL
    BONE MARROW TRANSPLANTATION, 2000, 26 (02) : 153 - 160
12345